- Investing Ideas
- Canadian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Canadian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
0 new
Value score of at least 4 focused on companies with a low market cap.
4 companies
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
4.8%
1Y
29.4%
Rubicon Organics
Market Cap: CA$30.1m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.46
7D
0%
1Y
4.5%
SOL Global Investments
Market Cap: CA$1.1m
A private equity firm specializing in emerging growth.
SOL
CA$0.04
7D
0%
1Y
-94.3%
Avant Brands
Market Cap: CA$8.7m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.58
7D
5.5%
1Y
-3.3%